“Comparing The Clinical Response Of Ormeloxifene, Evening Primrose Oil And Topical Diclofenac For Treatment Of Mastalgia In Benign Breast Disorders”

Mastalgia, or breast pain, affects up to 75% of women, often raising concerns about breast cancer. This study compares the efficacy of three treatments—ormeloxifene, evening primrose oil (EPO), and topical diclofenac—in reducing pain, nodularity, and lump size associated with benign breast disorders. A comparative study was conducted at Sharda Hospital from May 2023 to April 2024 with 48 patients aged 18–35 years and patients followed up at 4, 12 and 18 weeks. The results demonstrated significant improvement with ormeloxifene, in pain reduction, regression of breast nodularity and fibroadenoma, making it a promising treatment option.